13 subscribers
با برنامه Player FM !
Ep. 511 How to Simplify Dosing: Understanding Y-90 Dosimetry from Simple to Complex
Manage episode 462920043 series 2658136
Of all the topics covered during interventional radiology training, dosimetry education is often delayed until after IRs enter clinical practice. In this episode, Drs. Tyler Sandow and Sabeen Dhand host a roundtable discussion with experts on the dosimetry fundamentals that all Y90 operators should understand. They are joined by interventional radiologists Drs. Zachary Berman, Kirema Garcia-Reyes, and Siddharth Padia, who provide their expert insights.
Physicians, nurses, nurse practitioners, and physician assistants can follow this link to earn CME / CE credits for completing an accredited learning activity related to this discussion:
https://www.cmeuniversity.com/course/take/125736
---
This podcast is supported by an educational grant from AstraZeneca Pharmaceuticals and Boston Scientific.
---
SYNPOSIS
The group agrees that dosimetry is not a one-size-fits-all approach. Dosing strategies depend on factors such as tumor size, perfusion territory, underlying liver function, the choice between glass versus resin spheres, and treatment intent. These considerations are illustrated with real-life case examples. The doctors also explore voxel-based dosimetry, a method for calculating the amount of radiation absorbed by different parts of the tumor. They stress the importance of learning how to perform accurate dosage calculations.
Finally, the conversation touches on data from major Y90 trials, current guidelines, and the evolving perspective on Y90 as a potential curative treatment, rather than merely a bridging therapy.
---
TIMESTAMPS
00:00 - Introduction
01:59 - Dosimetry Education During Training
05:46 - Benefit of Individualized Dosing
11:01 - Complications from High Doses
15:19 - Dosage Calculation Cases
22:51 - Duration of Response to Y90
25:00 - Dosing Based on Treatment Intent
29:11 - Challenging Case Example
42:31 - Voxel-Based Dosimetry
45:15 - Using Dosimetry Software
---
RESOURCES
LEGACY Trial (Salem et al, 2021):
https://pmc.ncbi.nlm.nih.gov/articles/PMC8596669/
Voxel-based tumor dose correlates to complete pathologic necrosis after transarterial radioembolization for hepatocellular carcinoma (Pianka et al, 2024):
https://pubmed.ncbi.nlm.nih.gov/38913189/
RAPY90D Trial (Kappadath et al, 2023):
https://jnm.snmjournals.org/content/64/supplement_1/P268
Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group (Salem et al, 2023):
https://pubmed.ncbi.nlm.nih.gov/36114872/
International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres (Levillain, 2021):
https://link.springer.com/article/10.1007/s00259-020-05163-5)
CME Accreditation Information:
https://f7cae4ec-b69e-490d-9e0f-19b16a6f146d.usrfiles.com/ugd/f7cae4_a7c37ea3cd1b4d3fa53d5edf8dfe255b.pdf
557 قسمت
Manage episode 462920043 series 2658136
Of all the topics covered during interventional radiology training, dosimetry education is often delayed until after IRs enter clinical practice. In this episode, Drs. Tyler Sandow and Sabeen Dhand host a roundtable discussion with experts on the dosimetry fundamentals that all Y90 operators should understand. They are joined by interventional radiologists Drs. Zachary Berman, Kirema Garcia-Reyes, and Siddharth Padia, who provide their expert insights.
Physicians, nurses, nurse practitioners, and physician assistants can follow this link to earn CME / CE credits for completing an accredited learning activity related to this discussion:
https://www.cmeuniversity.com/course/take/125736
---
This podcast is supported by an educational grant from AstraZeneca Pharmaceuticals and Boston Scientific.
---
SYNPOSIS
The group agrees that dosimetry is not a one-size-fits-all approach. Dosing strategies depend on factors such as tumor size, perfusion territory, underlying liver function, the choice between glass versus resin spheres, and treatment intent. These considerations are illustrated with real-life case examples. The doctors also explore voxel-based dosimetry, a method for calculating the amount of radiation absorbed by different parts of the tumor. They stress the importance of learning how to perform accurate dosage calculations.
Finally, the conversation touches on data from major Y90 trials, current guidelines, and the evolving perspective on Y90 as a potential curative treatment, rather than merely a bridging therapy.
---
TIMESTAMPS
00:00 - Introduction
01:59 - Dosimetry Education During Training
05:46 - Benefit of Individualized Dosing
11:01 - Complications from High Doses
15:19 - Dosage Calculation Cases
22:51 - Duration of Response to Y90
25:00 - Dosing Based on Treatment Intent
29:11 - Challenging Case Example
42:31 - Voxel-Based Dosimetry
45:15 - Using Dosimetry Software
---
RESOURCES
LEGACY Trial (Salem et al, 2021):
https://pmc.ncbi.nlm.nih.gov/articles/PMC8596669/
Voxel-based tumor dose correlates to complete pathologic necrosis after transarterial radioembolization for hepatocellular carcinoma (Pianka et al, 2024):
https://pubmed.ncbi.nlm.nih.gov/38913189/
RAPY90D Trial (Kappadath et al, 2023):
https://jnm.snmjournals.org/content/64/supplement_1/P268
Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group (Salem et al, 2023):
https://pubmed.ncbi.nlm.nih.gov/36114872/
International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres (Levillain, 2021):
https://link.springer.com/article/10.1007/s00259-020-05163-5)
CME Accreditation Information:
https://f7cae4ec-b69e-490d-9e0f-19b16a6f146d.usrfiles.com/ugd/f7cae4_a7c37ea3cd1b4d3fa53d5edf8dfe255b.pdf
557 قسمت
सभी एपिसोड
×
1 Ep. 545 Outpatient PAE- Tips and Tricks from a High Volume Operator with Dr. Stephen "Andy" Vartanian 40:17

1 Ep. 544 Inside the RVS Update Committee (RUC) Process with Dr. Amar Rewari and Dr. Curtis Lee Anderson 36:16

1 Ep. 543 Metastatic Colorectal Cancer: Discussion on the COLLISION Trial with Dr. Martijn Meijerink 47:58

1 Ep. 542 Navigating Early Career in Interventional Radiology with Dr. Christopher Zarour and Dr. Kavi Devulapalli 58:23


1 Ep. 540 Dolor Crónico Femenino: Varices Pélvicas con Dr. Gloria Salazar 1:12:54

1 Ep. 539 The Future of the IR-DR Relationship with Dr. Saher Sabri and Dr. Mark Lessne 1:03:59

1 Ep. 538 Immunotherapy and TACE in HCC Treatment with Dr. Julius Chapiro and Dr. Richard Finn 1:07:37

1 Ep. 537 Keeping It Lean in the OBL with Dr. Mary Costantino 1:10:43

1 Ep. 536 Multidisciplinary Approaches to Renal Cancer Care with Dr. Louis Hinshaw and Dr. Jason Abel 39:36

1 Ep. 535 Genicular Artery Embolization: Current Controversies and Insights with Dr. Sid Padia and Dr. Osman Ahmed 1:26:54

1 Ep. 534 What’s a Good Job? Looking at the Diagnostic Job Market with Dr. Ned Holman and Dr. Mike Romeo 45:38

1 Ep. 533 Physician’s Guide to Financial Literacy and Investment Strategies with Dr. Jim Dahle 1:01:25


به Player FM خوش آمدید!
Player FM در سراسر وب را برای یافتن پادکست های با کیفیت اسکن می کند تا همین الان لذت ببرید. این بهترین برنامه ی پادکست است که در اندروید، آیفون و وب کار می کند. ثبت نام کنید تا اشتراک های شما در بین دستگاه های مختلف همگام سازی شود.